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Abstract 
Salmonella contamination of meat is a leading cause of foodborne illness around the 
world. Nontyphoidal Salmonella are responsible for an estimated 94 million infections and 
155,000 deaths worldwide each year. Of these infections, 86% are estimated to be foodborne. 
Infection of dairy and beef cattle can lead to contamination of milk and milk products as well as 
processed beef. Once cattle are infected, Salmonella can be found in many organs of the animals. 
Peripheral lymph node infections are of particular interest, because these lymph nodes along with 
hides are the main culprits of meat contamination during processing. 
Vaccination of production food animals is one of several strategies of prevention and 
control of Salmonella infections and outbreaks. Vaccination is becoming even more important 
with the reduction of prophylactic antibiotic use that is driven by an increase in antibiotic 
resistant bacteria isolated from a variety of food production animals. There are limited 
commercially available vaccines for cattle that have shown effectiveness, but great strides are 
being made in this area of research. The vast number of Salmonella serovars with differences in 
vital virulence factors capable of infecting cattle makes developing vaccines that are cross 
protective very difficult. This report discusses the known virulence factors of Salmonella, the 
disease symptoms of bovine salmonellosis, prevention and control strategies, and the 
development of new vaccines.  
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Chapter 1 - Introduction to Salmonella and Bovine Salmonellosis 
Salmonella enterica spp. enterica (Salmonella) is a genus of Gram-negative bacteria 
comprised of non-spore forming bacilli belonging to the Enterobacteriacea family (Coburn et 
al., 2007; Dunkley et al., 2009; Agbaje et al., 2011). The genus is comprised of two species, as 
described below (Reeves et al., 1989; Su and Chiu, 2007), and they are characterized by motility 
mediated by peritrichous flagella, and facultative anaerobic metabolism (Coburn et al., 2007; 
Agbaje et al., 2011; Andino and Hanning, 2014). Like other Enterobacteriacea, Salmonella live 
in the gastrointestinal tract, often without evidence of clinical disease, of many mammals, birds, 
reptiles and fish, but also Salmonella can persist in the environment (Sanchez et al., 2002; 
Callaway et al., 2014). The genus is named after D.E. Salmon who, along with Theobald Smith 
discovered and isolated “bacillus cholerasuis” (now known as Salmonella Choleraesuis) from 
porcine intestines in 1884 (Agbaje et al., 2011). Salmonella nomenclature is very complex and 
there have been many changes in conventional naming schemes throughout the history of the 
genus (Salyers 2002; Bopp et al., 1999). Originally, salmonellae were separated into different 
“serovars” (also called “serotypes”) according to a scheme of serological classification of poly-O 
(cell wall) and H (flagellar) antigens described by Kaufman and White, who also proposed that 
each serovar be considered a separate species (Brenner et al., 2000).  Currently, there are 67 O-
antigens and 117 H-antigens that have been identified (Grimont and Weill, 2007; Popoff, 2001). 
According to the current Centers for Disease Control and Prevention (CDC) system, the genus 
Salmonella consists of two species: Salmonella enterica and Salmonella bongori (Su and Chiu, 
2007). Within Salmonella enterica, there are six subspecies: enterica, salamae, arizonae, 
diarizonae, houtenae, and indica (Figure 1-1) (Su and Chiu, 2007). Salmonella enterica spp. 
enterica is most relevant to animal disease and responsible for 99% of human Salmonella 
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infections (Uzzau et al., 2000). Salmonella enterica spp. enterica can be further classified into 
serovars (Fierer and Guiney, 2001) and more than 2,600 serovars have been described (Table 1-
1) (Grimont and Weill, 2007; Hendriksen et al., 2009). 
 
 
 
Figure 1-1 Classification of Salmonella species and subspecies. 
Adapted from Hurley D, McCusker MP, Fanning S, Martins M. (2014). Salmonella—host 
interactions—modulation of the host innate immune system. Frontiers in Immunology 5(481):1-
11. 
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Table 1-1 Currently recognized number of Salmonella serovars 
Adapted from Issenhuth-Jeanjean S, Roggentin P, Mikoleit M, Guibourdenche M, de Pinna E, 
Nair S, Fields P, Weill FX. (2014). Supplement 2008-2010 (no. 48) to the White—Kauffmann—
Le Minor scheme. Research in Microbiology, 165 (7): 526-530. 
Salmonella species and subspecies No. of serovars 
S. enterica 2637 
S. enterica spp. enterica 1586 
S. enterica spp. salamae 522 
S. enterica spp. arizonae 102 
S. enterica spp. diarizonae 338 
S. enterica spp. houtenae 76 
S. enterica spp. indica 13 
S. bongori 22 
Total (genus Salmonella) 2659 
 
Salmonella is distributed worldwide and is a leading cause of acute bacterial 
gastroenteritis in people. Except for serovars Typhi and Paratyphi, domestic and wild animals are 
the natural reservoirs for all other Salmonella serovars. This fact highlights the zoonotic potential 
of this pathogen. In the U.S., 5 of the 10 most commonly isolated Salmonella serovars in humans 
belong to serogroup C (See Table 3-1). Research into veterinary vaccines to reduce the infection 
of animals by Salmonella serogroup C organisms to reduce the likelihood of human foodborne 
infection is lacking. 
 The types of human disease that are caused by Salmonella are classified into two major 
categories: typhoidal and non-typhoidal salmonellosis (Coburn et al., 2007). Typhoidal disease 
(or typhoid fever) is a systemic disease generally caused by S. enterica subsp. enterica serovar 
Typhi in humans (Coburn et al., 2007). Salmonella Paratyphi causes a similar but milder disease 
called paratyphoid fever (Figure 1-1). Other Salmonella serovars cause typhoid-like disease in 
other animals (for example, Dublin in cattle and Typhimurium in mice) (Costa et al., 2012). 
Clinical signs and symptoms of typhoidal disease in humans include bacteremia, fever, nausea, 
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anorexia, myalgia and headache (Heymann, 2008). Gastrointestinal symptoms are not a primary 
feature of typhoidal disease. In contrast, non-typhoidal salmonellosis is primarily an infection of 
the gastrointestinal tract (enteritis) and is characterized by fever, diarrhea, malaise, nausea, and 
vomiting (Coburn et al., 2007). 
 Prevalence of Salmonella 
 Meat vs. Milk 
Although poultry and eggs are the most commonly implicated foods in cases of human 
foodborne salmonellosis (Gould et al., 2013), many meats, including beef, are subject to 
Salmonella contamination and represent important sources of Salmonella foodborne illnesses 
(Gould et al., 2013; McEntire et al., 2014; Crowe et al., 2015; Laufer et al., 2015). Among 1,965 
Salmonella outbreaks reported to the CDC between 1973 and 2011 in which a specific food was 
identified, five percent were attributed to beef. These outbreaks were responsible for 3,684 
illnesses, 318 hospitalizations, and five deaths (Laufer et al., 2015). Analyses of outbreak data 
between 1998 and 2008 identified beef  in 10% of Salmonella outbreaks (Gould et al., 2013) and 
the fourth most common cause of salmonellosis in the U.S. (McEntire et al., 2014). In more 
recent summaries of outbreak data between 2010 and 2014, contaminated beef was responsible 
for five outbreaks of Salmonella (Crowe et al., 2015).  
According to the CDC, in 2016 an outbreak of S. Montevideo occurred in 9 states and 
was linked to contaminated pistachios. S. Montevideo is a serovar that is commonly isolated 
from cattle (Table 1-2). The contamination of pistachios could have occurred by spreading 
Salmonella containing cattle manure on fields. Another recent Salmonella outbreak linked to 
cattle occurred in 2016. The CDC investigated the outbreak and concluded that 36 people in 10 
states were infected with a multidrug-resistant S. Heidelberg. This outbreak was linked to dairy 
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bull calves, so it is unlikely that the outbreak was due to consuming contaminated meat. The 
human infections likely were a result of handling sick or dead animals. During the investigation 
of this outbreak, multiple farms and markets were implicated in the spread of the outbreak strain 
of S. Heidelberg.  
The S. Montevideo and S. Heidelberg outbreaks demonstrate the need for cross-protective 
vaccines. S. Montevideo is a serogroup C bacterium, whereas S. Heidelberg is a serogroup B 
bacterium. A broadly cross-protective vaccine could protect cattle from both of these serogroups, 
and if cattle are protected the outbreaks in people could possibly avoided. 
Milk and other dairy products are less likely to contain Salmonella because of 
commercial pasteurization, reducing the likelihood of infections from these items. A portion of 
the population consumes products that are not pasteurized; therefore, they have the potential to 
be infected with contaminated dairy products. For example, an outbreak of S. Typhimurium in 
four states occurred in 2002-2003 due to the consumption of unpasteurized milk products (CDC, 
2003). More recently, 8 outbreaks in 5 states occurred between 2013-2015 due to the 
consumption of raw milk or unpasteurized milk products (CDC FOOD Tool). Several 
Salmonella serotypes were implicated in the outbreaks including Mbandaka, Newport, 
Typhimurium, and Montevideo. Most milk is tested with commercial test kits, such as an 
enzyme-linked immunosorbent assay (ELISA), before shipping to a processing facility. Milk that 
is determined to be positive for Salmonella contamination is often destroyed. 
 Fecal Shedding: Dairy vs. Beef Cattle 
Salmonella infected dairy cattle can pose a large risk to public health if they are culled 
and enter the food supply as beef products. The ground beef produced from these animals can 
contain peripheral lymph nodes that have been colonized by Salmonella (pathogenesis is 
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discussed in detail below). There have been several cases of human Salmonella outbreaks traced 
back to dairy farms (Holmberg et al., 1984; Spika et al., 1987) The 1996 USDA survey of dairy 
cattle, National Animal Health Monitoring System (NAHMS) Dairy ’96, reported that 14.9% of 
culled dairy cows were shedding Salmonella and 66.7% of dairy cull markets had at least 1 
animal shedding the bacteria. The USDA NAHMS Dairy ’96 study also found that 27.5% of 
U.S. dairy operations and 5.4% of milk cows shed Salmonella. The USDA NAHMS Dairy 2007 
report showed an increase in the percentage of dairy operations and milk cows that shed 
Salmonella when compared to 1996. In 2007, 39.7% of dairy operations and 13.8% of milk cows 
shed Salmonella. The increase of Salmonella shedding by dairy cattle indicates that even with 
increased awareness and better biosecurity practices, the problem of Salmonella infections in 
cattle is an increasing problem that cannot be curtailed by management practices alone. 
Vaccination for Salmonella with a broadly cross-protective vaccine could help reduce the 
incidence of Salmonella shedding by cattle. 
The prevalence of beef cattle shedding Salmonella has been investigated several times. 
Dodd et al. (2011b) estimated the prevalence of beef cattle shedding Salmonella at feedlot entry 
in the U.S. to be 64.7% and 72.6% at harvest. These numbers suggest that the prevalence of beef 
cattle that shed Salmonella is much greater than the prevalence of dairy cattle shedding 
Salmonella. While beef cattle can shed a number of Salmonella serovars, a few serovars make up 
most of the recovered isolates. According to Dodd et al. (2011b), 86% of recovered isolates can 
be attributed to just 5 serotypes (Table 1-2).  It is estimated that about 1% of feedlot cattle are 
vaccinated against any Salmonella serovar. Currently available commercial vaccines have either 
shown no, or very slight cross-protection against multiple serovars of Salmonella.  For example, 
a S. Newport bacterial extract siderophore receptor and porin protein vaccine was evaluated for 
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efficacy in beef cattle. In short, Salmonella use siderophores and porins to transport iron into the 
bacterial cell, which is critical for bacterial survival. The vaccine is designed to induce 
production of anti-siderophore receptor and anti-porin protein antibodies by the host immune 
system. Once the antibodies are bound to the targets, the bacteria are no longer able to transport 
iron, which is critically important for cell homeostasis, and die (Kingsley et al., 1995). Dodd et 
al. (2011a) found no difference between Salmonella fecal shedding, mortality, or morbidity 
among vaccinated and control animals. 
Another example is a modified live S. Choleraesuis vaccine licensed for use in swine, 
Enterisol SC-54®, was evaluated for efficacy against S. Dublin infection in cattle. The vaccine 
significantly reduced clinical signs and bacterial shedding (Fox et al., 1997), but it was never 
licensed for use in cattle. An increase in the number of animals vaccinated has the potential to 
reduce the prevalence of beef calves shedding Salmonella, but to convince producers to 
vaccinate their animals, a cross-protective vaccine must be developed that can protect against the 
most commonly isolated serotypes. 
 
Table 1-2 Most commonly isolated Salmonella serovars from beef cattle. 
Adapted from Dodd CC, Renter DG, Shi X, Alam MJ, Nagaraja TG, Sanderson MW. (2011). 
Prevalence and persistence of Salmonella in cohorts of feedlot cattle. Foodborne Pathogens and 
Disease, 8(7): 781-789. 
 
Serotype Serogroup No. of isolates Percent of isolates 
Anatum E 347 28.6% 
Montevideo C1 261 21.5% 
Orion E 206 17.0% 
Kentucky C3 123 10.1% 
Mbandaka C1 110 9.1% 
Others Multiple 167 13.8% 
Total NA 1214  
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Peripheral Lymph Node Colonization 
How Salmonella migrate from the gut to systemic tissues has yet to be completely 
identified, but there are several theories under investigation. One theory is that bacteremia 
mediates the movement of Salmonella from the gut to the peripheral tissues. Septicemia is a 
common occurrence in calves dying from salmonellosis as described below. Salmonella can be 
isolated from the blood of calves as early as 2-4 hours post infection (de Jong and Ekdahl, 1965; 
Pullinger et al., 2007). de Jong and Ekdahl (1965) performed esophagectomies on calves to 
prevent dissemination of an experimental S. Typhimurium challenge from the gut to the 
peripheral lymph nodes (PLNs), but they were still able to isolate the organism from PLNs. This 
study showed that the dissemination of Salmonella does not only involve the alimentary canal, 
and supports the theory of migration of Salmonella through bacteremia. 
Another mechanism under investigation is that the lymphatic system mediates the 
movement of Salmonella bacteria from the gut to the PLNs (Uzzau et al., 2000; Paulin et al., 
2002; Pullinger et al., 2007; Brown et al., 2015). In general it is believed that the bacteria are 
simply disseminated once in the lymphatic system. 
The final theory is that a route of infection that was not previously thought to be an 
important factor in bovine Salmonella infections may play a much larger role than previously 
thought. Several recent studies have shown that Salmonella may be disseminated to PLNs when 
a cow is infected transdermally by biting flies or hide abrasions (Edrington et al., 2013; Gragg et 
al., 2013; Brown et al., 2015). A transdermal infection in the area of the PLNs of interest could 
result in the dissemination of Salmonella to the lymph nodes because of the large number of 
dendritic cells that would be present in the area. Once Salmonella becomes phagocytosed by the 
dendritic cell, it could be transported to the nearest PLN. 
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PLN colonization is important because these lymph nodes are likely to be contained in 
ground beef. Unlike mesenteric lymph nodes, which are easily removed, PLNs are very small, 
and it is not practical to remove all of the PLNs at slaughter. The first study that showed PLNs as 
a source of ground beef contamination estimated Salmonella prevalence in chuck and flank 
lymph nodes at 1.6% (Arthur et al., 2008). Several other studies have estimated the prevalence of 
Salmonella in PLNs from the same regions as high as 88.2% (Haneklaus et al., 2012). Even if 
the prevalence of Salmonella infected PLNs are much lower, a high risk of Salmonella outbreaks 
associated with ground beef is assured, especially if the beef is undercooked.  
Several Salmonella serotypes have been isolated from PLNs. Gragg et al. (2013) found 
that of the serotypes isolated from subiliac lymph nodes in the flank region of feedlot and cull 
cattle, 44% were S. Montevideo and 24.8% were S. Anatum. Currently in the U.S., there are no 
licensed vaccines targeting either of these serovars. These two serovars belong to different 
serogroups, suggesting that if vaccination is used as a prevention strategy, a cross-protective 
vaccine will be necessary.  
 Bovine Salmonellosis 
Clinical cases of bovine salmonellosis are usually observed as a syndrome of septicemia, 
acute or chronic enteritis or abortion. One or more of these syndromes may occur at the same 
time in the same animal or herd. Animals may also become asymptomatic latent carriers of 
Salmonella, capable of shedding without clinical signs of disease. Young calves, three months or 
younger, are most commonly affected, although animals exposed to stressful environments are 
also at risk to contract the disease. Although salmonellosis in cattle can be caused by many 
different serovars, Salmonella Dublin and S. Typhimurium are the most common (Meara, 1973; 
Radostits et al., 1994). S. Cerro is also an emerging serovar of interest in the United States, 
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having caused a large outbreak of antibiotic resistant cases in Wisconsin in 2015 (Valenzuela et 
al., 2017). The source of infection is usually an environment contaminated by the feces of other 
infected animals.  
Salmonellosis in both calves and adult cattle occurs in most countries in the world and 
has been shown to be economically important in Europe and North America (Hungerford, 1990; 
Radostits et al., 1994). The cost associated with bovine salmonellosis is due to the cost of 
clinical disease including death, diagnosis and treatment of clinical cases, diagnostic laboratory 
costs, cleaning and disinfection, and the cost of control and prevention. Estimated annual costs 
for salmonellosis have ranged from billions of dollars in the United States to hundreds to 
millions of dollars in Canada and millions of pounds in United Kingdom. Analysis of five 
Salmonella outbreaks due to manufactured food in North America gave direct costs with ranges 
from $36.4-$62 million. There have been few studies on the cost-benefit ratio of preventing 
Salmonella infection, but it has been suggested that for every $1 spent on investigation and 
curtailment of an outbreak, there is a savings of $5 (Wray et al., 1991). 
 Pathogenesis of Salmonellosis 
Salmonella bacteria are facultative intracellular organisms and survive in macrophage 
phagolysosomes where they are protected from antibodies and the effect of complement 
activation (Radostits et al., 1994). This is very important in latent carriers, where stress can 
induce active shedding of Salmonella. The outcome of infection with Salmonella depends on 
three factors: the size of the infective dose, host predisposition, and the level of immunity 
(Barker et al., 1993; Rings, 1985; Williams, 1980).  
In bovine salmonellosis, either the intestinal tract is the only organ involved, or 
organisms may spread beyond the intestinal mucosa and mesenteric lymph nodes resulting in 
11 
septicemia or bacteremia and dissemination to the liver, tonsils, spleen, lung, and peripheral 
lymph nodes. Salmonella may also localize in the joints, meninges and placenta (Barker et al., 
1993; Hall and Jones, 1977; Kennedy et al., 1993; Rings, 1985; Segall and Lindberg, 1991; 
White et al., 1981).  
For enteric lesions, the pathogenesis of this disease has two stages; first, colonization and 
invasion of the intestine by the bacteria, which is then followed by increased secretion of fluid 
and electrolytes (Barker et al., 1993; Murray 1986). Salmonella must be ingested in sufficient 
numbers for colonization of the small intestine and colon to occur, normally at least 10
4
 
organisms (Barker et al., 1993; Morse and Duncan, 1974; Segall and Lindberg, 1991; Smith et 
al., 1979; Wray and Sojka, 1977; Wray and Sojka, 1978). Any factors that interfere with and 
disrupt the normal intestinal flora, such as antibiotic treatment, decreased food and water intake, 
or stress from transport, may enhance colonization in the small intestine (Clarke et al., 1986; 
Hentges and Maier, 1970; Timoney et al., 1988).  
The ability of the bacteria to attach and invade enterocytes is essential for the 
development of enteric salmonellosis (Barker et al., 1993). The main site of invasion is the distal 
ileal mucosa, and high numbers of Salmonella can be recovered here shortly after oral infection 
of calves (Watson et al., 1995). Pili enable the bacteria to become attached to the surface of 
enterocytes, facilitating their entrance into the cells. The bacteria also invade the mucosa through 
the intercellular junctional complexes (Barker et al., 1993). Salmonella remain intact in the 
membrane-bound vacuoles in the enterocyte cytoplasm, multiplying and producing enterotoxin 
(Barker et al., 1993). Enterotoxins will be discussed in more detail below. Most of the bacteria 
are located in the membrane bound vacuoles within macrophages and neutrophils in the lamina 
propria, part of the gastrointestinal wall under the epithelium and containing several different 
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immune cells, by 24 hours post infection (Barker et al., 1993; Clarke et al., 1986). The 
Salmonella may spread to the regional lymph nodes, where further multiplication takes place.  
Salmonella infection can stimulate secretion of increased amounts of fluids and 
electrolytes. Enterotoxins and the inflammatory response following invasion of the intestinal 
mucosa causes the release of prostaglandins that activate mucosal adenyl-cyclase, resulting in a 
net secretion of water, Na
+
, HCO3
-
, and Cl
-
 into the intestinal lumen. (Murray, 1986; Rings, 
1985; Turnbull, 1979). Malabsorption and maldigestion develop as a result of cellular infiltration 
of affected intestine and damage to the villi restricting lymph and blood flow, diminishing the 
absorptive surface area (Rings, 1985). 
 Virulence Factors 
The pathogenesis of Salmonella is dependent on the ability of the bacteria to invade and 
evade host cells in order to survive and replicate. Salmonella produce many virulence factors, 
which are molecules or sets of molecules that enable the bacteria to replicate and disseminate 
within a host by evading or subverting host defenses. As discussed below, virulence factors such 
as virulence plasmids, toxins, fimbriae, and flagella, allow Salmonella to colonize and survive in 
an inhospitable environment. Other virulence factors such as Salmonella pathogenicity islands 
that encode protein secretion systems allow the bacterium to penetrate cells and contribute to 
bacterial persistence and pathogenicity.  
 Virulence Plasmids 
A feature of serovars that more commonly cause systemic infections is the presence of 
plasmid encoded spv (Salmonella plasmid virulence) genes essential to bacterial multiplication 
within the reticulo-endothelial system of hosts (Rotger and Casadesus, 1999). Virulence 
plasmids house five genes designated as spv RABCD (van Asten and van Dijk, 2005). These spv 
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genes promote enhanced intracellular proliferation in intestinal tissues as well as extra-intestinal 
sites in the host. The spv genes are found in nearly all Salmonella isolates that are host-adapted 
to animals, but only a few broad-host-range serovars (Libby et al., 1997). 
 Toxins 
Two forms of toxins aid in bacterial invasion by Salmonella: endotoxins and 
enterotoxins. Endotoxins are cell-associated bacterial toxins. Most commonly, endotoxins are 
imbedded in the outer membrane of Gram-negative bacteria and are synonymous with 
lipopolysaccharide (LPS). The toxicity of LPS results from the ability of lipid A to perpetuate 
immune responses such as the release of tumor necrosis factor (TNF)-α, interleukin-1β, and 
mammalian inducible nitric oxide synthase (iNOS). The release of the pro-inflammatory 
mediators is an indication of endotoxins causing harm to the host (Khan et al., 1998). 
Exotoxins are proteins that modify the host environment and cell functions, such as 
cytoskeleton dynamics, vesicular trafficking, morphology of host plasma membrane, and 
immune responses in order to gain entry into targeted cells (Spanò et al, 2008; Suárez and 
Rüssmann, 1998). Exotoxins can be considered either cytotoxins or enterotoxins (van Asten and 
van Dijk, 2005) and are distributed by a simple release into the cytoplasm of cells under the 
guidance of a chaperone protein or via protein secretion systems such as type III secretion 
systems or type IV secretion systems (Spanò et al, 2008). 
 Fimbriae 
Fimbriae, also referred to as pili, are significant elements for virulence through the initial 
bacterial invasion of the intestinal tract by mediating adhesion to the epithelial cells of the 
intestine (Stevens et al., 2009). Fimbriae are located on the outer membrane of Salmonella and 
are 2 to 8 nm wide and 0.5 to 10 μm long (van Asten and van Dijk, 2005). Fimbrins, helically 
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arranged repeating proteins, are the primary components of fimbriae. Salmonella fimbriae adhere 
the bacteria to the M-cells, which are specialized epithelial cells of the intestinal mucosa that 
transport antigens from the lumen to other cells of the immune system to initiate an immune 
response (Edwards et al., 2000). There have been 13 fimbrial loci determined for Salmonella, 
one of which is the adhesin, FimH. FimH has been shown to assist in the uptake of bacteria into 
murine dendritic cells independent of secretion systems (Ibarra and Steeele-Mortimer, 2009). It 
can be theorized that FimH could be a vaccine candidate that could stimulate an immune 
response that could prevent Salmonella from colonizing dendritic cells and to prevent the spread 
of Salmonella through the lymphatic system. 
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Figure 1-2 A dividing pair of Salmonella displaying both its peritrichous flagella and 
fimbriae. 
Adapted from Todar K. (2008) Todar’s Online Textbook of Bacteriology Chapter 3: Structure 
and Function of Prokaryotes. Page 3 of 10. Retrieved from 
http://textbookofbacteriology.net/kt_toc.html. 
 
 Flagella 
As a virulence factor, flagella are most important for the initial stage of pathogenicity by 
allowing Salmonella to swim to target cells within the host, facilitating host cell invasion. 
Flagella are long helical filaments attached to rotary motors embedded in the bacterial membrane 
and are designed for swimming or swarming (Saini et al., 2010). Over 50 genes are required to 
synthesize the basal body, hook, and a filament of flagella (Uchiya et al., 2009). The filaments of 
flagella are comprised of a protein called flagellin, which is often recognized as pathogen 
associated molecular patterns (PAMPs) by host’s immune system, thereby activating the 
expression of proinflammatory cytokines (Saini et al., 2010; Zipfel et al., 2004). 
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Figure 1-3 The structure of the bacterial flagellum as it resides within the cell wall and 
membranes. 
Adapted from Acharya T. (2013). Bacterial flagella: Structure, importance and examples of 
flagellated bacteria. Microbe Online. http://microbeonline.com/bacterial-flagella-structure-
importance-and-examples-of-flagellated-bacteria/  
  
 Protein Secretion Systems and Salmonella Pathogenicity Islands 
Seven different types of protein secretion systems (types I-VII) have been identified in 
Salmonella (Leung et al., 2010). These protein secretion systems allow bacteria to transport 
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proteins across phospholipid membranes, which may be from the bacteria into the host cell. Type 
III secretion systems resemble a molecular syringe (Figure 1-4) delivering virulence proteins 
capable of manipulating host-cell functions such as signal transduction, cytoskeletal 
rearrangement, membrane trafficking, and cytokine expression. These manipulations allow for 
bacterial survival and proliferation. Type III secretion system-1 mediates Salmonella invasion of 
epithelial cells, and type III secretion system-2 is essential for macrophage survival (Forest et al., 
2010; Raffatellu et al., 2008). Type VI secretion system plays a role in bacterial infection, 
intracellular survival, biofilm formation, flagella regulation, quorum sensing, and stress response 
for Salmonella (Leung et al., 2010).  
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Figure 1-4 Cartoon of the Salmonella type III secretion system. 
Adapted from Tang YT, GAO R, Havranek JJ, Groisman EA, Stock AM, Marshall GR. (2012). 
Inhibition of bacterial virulence: drug-like molecules targeting the Salmonella enterica PhoP 
response regulator. Chemical Biology & Drug Design, 79(6): 1007-1017. 
 
S. Typhimurium is capable of releasing proteins via the type III secretion system that 
provoke its own uptake into target host cells. Once in the host cell, S. Typhimurium releases 
additional effectors via a secondary type III secretion system to impair phagosome maturation, 
generate Salmonella-containing vacuoles (SCVs), and prevent phagosome-lysosome fusion 
(Bischofberger and van der Goot, 2008; Ohl and Miller, 2001). Type III secretion system-2 can 
prevent fusion of NADPH-dependent oxidase with SCVs which inhibits the production of 
reactive oxygen species inside the vacuole. Type III secretion systems are highly conserved, but 
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the effector proteins released are variable resulting in distinct virulence patterns (Ohl and Miller, 
2001).  
Type III secretions systems are regulated through Salmonella pathogenicity islands, 
which are clusters of virulence genes located either on the bacterial chromosome or in virulence 
plasmids (Figure 1-5). There have been 12 Salmonella pathogenicity islands identified (Lahiri et 
al., 2010). Salmonella pathogenicity island-1 regulates type III secretion system-1 and is 
essential to the initiation of bacterial infection and invasion of the intestinal tract. Salmonella 
pathogenicity island-2 regulates type III secretion system-2 and is crucial for bacterial survival 
within host macrophages (Hansen-Wester and Hensel, 2001; Lahiri et al., 2010; Suárez and 
Rüssmann, 1998). Salmonella pathogenicity island-2 operons are regulated by a two-component 
regulatory system, SsrA/SsrB (Forest et al., 2010). 
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Figure 1-5 Schematic illustration of the genes of Salmonella pathogenicity island-1 and 
Salmonella pathogenicity island-2 indicating their functional categories. 
In Salmonella, salmonella pathogenicity island-1 and salmonella pathogenicity island-2 encode a 
range of effector proteins, secretion apparatus, and transcriptional regulators in addition to type 
III secretion system-1 and type III secretion system-2. Adapted from Hurley D, McCusker MP, 
Fanning S, Martins M. (2014). Salmonella—host interactions—modulation of the host innate 
immune system. Frontiers in Immunology, 5(481): 1-11. 
 
 Two-Component Regulatory Systems 
Two-component regulatory systems allow bacteria to interact with their environment by 
sensing and responding to changes outside of the bacterial cell (Stock et al., 2000). Two-
component regulatory systems are comprised of a histidine protein kinase and a response 
regulator. Changes in the external environment activate the histidine protein kinase, which in 
turn phosphorylates the response regulator. This phosphorylation results in the activation of an 
effector domain that produces a response for the change in the environmental condition (Stock et 
al., 2000). These two-component regulatory systems allow Salmonella to respond effectively to 
harsh host environments including nitrogen and phosphate limitation, sugar transport, and 
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osmolarity, by regulating the effector proteins (Miller et al., 1989). One important two-
component regulatory system is the PhoQ/PhoP signal transduction system (Figure 1-6). PhoQ is 
the sensor histidine kinase, and PhoP is the response regulator. PhoQ senses low extracellular 
magnesium levels, leading to autophosphorylation at a conserved histidine residue. PhoQ 
transfers to phosphate group to a conserved aspartate residue on PhoP. Phosphorylation of PhoP 
mediates activation by causing a conformational change, allowing PhoP to homodimerize. PhoP 
recognizes phoP boxes at its DNA promoters and function as a transcription factor to regulate 
virulence gene expression (Tang et al., 2012). 
 
 
 
Figure 1-6  Schematic diagram of the Salmonella enterica PhoQ⁄PhoP two-component 
signal transduction system.  
Adapted from Tang YT, GAO R, Havranek JJ, Groisman EA, Stock AM, Marshall GR. (2012). 
Inhibition of bacterial virulence: drug-like molecules targeting the Salmonella enterica PhoP 
response regulator. Chemical Biology & Drug Design, 79(6): 1007-1017. 
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Disease symptoms 
Calves may develop peracute, acute, or chronic salmonellosis. In addition, it has been 
found that approximately 5% of apparently healthy calves are asymptomatic carriers of 
Salmonella (McGuirk and Peek, 2003). The peracute disease is usually a septicemic condition 
that is often fatal. Calves may die suddenly without the onset of symptoms being visualized 
(Rings, 1985). Some calves develop enteritis and diarrhea in addition to septicemia. (Anderson 
and Blanchard, 1989; Williams, 1980). Protracted septicemia may result in the development of 
hepatitis, pneumonia, meningoencephalitis, polyarthritis, and osteomyelitis (Anderson and 
Blanchard, 1989; Bulgin, 1983; Power and O’Keefe, 1991; Richardson, 1975). 
Acute enteric salmonellosis is the most common syndrome of Salmonella infection in 
calves (Anderson and Blanchard, 1989; Rings, 1985; Wray and Sojka, 1977). Calves develop a 
high fever after an incubation period that is variable between 1-5 days. Other symptoms that may 
be present are inappetence, lethargy, depression, diarrhea, polypnea, nasal discharge, and 
coughing (Roy, 1990; Segall and Lindberg, 1991; Smith et al., 1979). The feces will smell foul, 
be a putty-like to watery consistency, and may contain blood, mucus, and sloughed mucosa 
(Anderson and Blanchard, 1989; Segall and Lindberg, 1991; Smith et al., 1979). Calves may 
show signs of colic, become weaker and dehydrated, and become recumbent. As the disease 
progresses, body temperature may become subnormal (Wray and Sojka, 1978). 
Chronic salmonellosis in calves is characterized by unthriftiness, scruffy hair coats, and 
stunting of growth (Rings, 1985; Wray and Sojka, 1977). Diarrhea is not always present, but 
signs of chronic pneumonia and persistent coughing may occur (Hungerford, 1990; Rings, 1985). 
Calves that survive any of the three salmonellosis syndromes may develop pneumonia, 
meningoencephalitis, purulent polyarthritis of the carpal and tarsal joints, and osteomyelitis 
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resulting in lameness (Gitter et al., 1978; Power and O’Keefe, 1991; Rings, 1985; Van den 
Heever, 1955). Cattle can also become carriers of Salmonella and either shed the organism 
continuously or intermittently. These animals become Salmonella reservoirs on farms and can 
cause an endemic disease state on the farm. Carrier animals can shed up to 10
9
 Salmonella 
bacteria in their feces per day (McGuirk and Peek, 2003). 
Adult cattle generally contract either acute or subacute enteric salmonellosis. Pregnant 
animals may abort following infection (Kahrs et al., 1972; Williams, 1980; Wray, 1991; Wray 
and Sojka, 1977). During early stages of the acute enteric disease, animals show fever, 
depression, inappetence, and low milk yield followed by foul-smelling diarrhea. The feces are 
usually mucoid with blood clots and shreds of necrotic intestinal mucosa (Carter et al., 1983; 
Richardson, 1975; Stadler and Nesbit, 1990). Affected animals may show signs of colic, 
congestion, and dehydration (Radostits et al., 1994). The acute disease will last about one week 
with a fatality rate of about 50% (Richardson, 1974; Richardson and Watson, 1971). Animals 
may take over two months to completely recover (Hughes et al., 1971; Williams, 1980). 
Animals suffering from subacute enteric salmonellosis present with similar but less 
severe signs as the acute syndrome (Stadler and Nesbit, 1990; Williams, 1980).  Most affected 
animals recover without treatment (Williams, 1980).  
Salmonella Dublin in particular, but other serovars as well, may cause abortion in cows at 
any stage of pregnancy (Hall and Jones, 1979; Hinton, 1971; Hinton, 1974; Kahrs et al., 1972). 
Abortions may precede the onset of dysentery or follow it in 2-4 weeks. Abortion may also 
follow pyrexia or may be the only sign of disease (Hall and Jones, 1976; Hinton, 1974; Hughes 
et al., 1971; Richardson, 1971). Decomposition is a common feature in aborted fetuses (Hall and 
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Jones, 1977). Approximately 70% of cows that abort retain the placenta, but subsequent fertility 
is not usually affected (Hall and Jones, 1976; Hall and Jones, 1979).  
 Pathology 
Calves affected by peracute septicemic salmonellosis show leukopenia with a left shift, 
meaning there are an abnormal number of immature neutrophils indicating an acute 
inflammation. Metabolic acidosis may be present with or without diarrhea or dehydration (Rings, 
1985). In calves with enteritis, leukopenia is present early, but leukocytosis and an elevated 
plasma fibrinogen level develops after three or four days. Dehydration results in elevated packed 
cell volume and plasma protein levels (Rings, 1985; Smith et al., 1979; White et al., 1981). 
Calves suffering from diarrhea have decreased serum sodium and chloride levels, while 
potassium levels can be either elevated or decreased (Rings, 1985; Wray, 1980). Blood urea 
levels may rise markedly and be of value in prognostication (Wray, 1980). Plasma bilirubin 
levels are raised in calves with cholestasis because of interference in bilirubin excretion by 
bacterial metabolites (White et al., 1981). Calves that have died from peracute septicemic 
salmonellosis have widespread subcutaneous, mucosal, and serosal petechial hemorrhages, 
generalized congestion, edema and congestion of the lungs, splenomegaly and hepatomegaly 
(Barker et al., 1993; Rings, 1985; White et al., 1981). 
Calves dying from acute enteric salmonellosis suffer from varying degrees of dehydration 
and possible mild icterus (White et al., 1981; Williams, 1980; Wray and Sojka, 1978). The 
calves show moderate hepatomegaly, and the liver is bronze or orange-brown. The liver may also 
have a few to numerous foci of necrosis, 0.5 to 1.0 mm in diameter. There may also be a few 
petechial hemorrhages disseminated throughout the parenchyma (White et al., 1981). The gall 
bladder may be distended with the wall being edematous, and there may be focal necrosis of its 
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mucosa or hemorrhages in the wall (Figure 1-9) (White et al., 1981). The spleen may be 
moderately enlarged with necrotic foci in the red pulp, similar to the foci in the liver (Barker et 
al., 1993). Small areas of acute bronchopneumonia, with or without hemorrhages in the lung 
parenchyma and a fibrinous pleural exudate, may be present (White et al., 1981). The kidneys 
may be swollen with small necrotic foci in the renal cortex (Barker et al., 1993; White et al., 
1981; Williams, 1980). Lesions in the gastrointestinal tract vary in severity and location. S. 
Dublin infections cause multiple erosions and petechiae in the abomasal mucosa (Figure 1-11) 
(Rings, 1985).  In most calves, the jejunum and ileum are affected. Depending on the disease 
severity, catarrhal, necrotizing, or diphtheritic jejunitis and ileitis may be present (Figure 1-8) 
(Barker et al., 1993; Robinson, 1966; Segall and Lindberg, 1991; Wray and Sojka, 1977). In 
some animals, the cecum and colon show similar lesions to the small intestine. The contents of 
the intestine are watery, foul-smelling, and contain fibrin (Figure 1-7), mucus, desquamated 
mucosa, and digested blood (Wray and Sojka, 1977). The mesenteric lymph nodes are enlarged 
and edematous with possible petechiae on the interior (Figure 1-10). 
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Figure 1-7 Fibrin deposits in the small intestine of a calf with salmonellosis. 
Adapted from Mohler VL, Izzo MM, House JK. (2009). Salmonella in calves. Veterinary Clinics 
of North America: Food Animal Practice, 35(1): 37-54. 
 
Figure 1-8 Catarrhal hemorrhagic enteritis in a calf with salmonellosis. 
Adapted from Mohler VL, Izzo MM, House JK. (2009). Salmonella in calves. Veterinary Clinics 
of North America: Food Animal Practice, 35(1): 37-54. 
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Figure 1-9 Ulcerated bile ducts in the gall bladder. 
Adapted from Mohler VL, Izzo MM, House JK. (2009). Salmonella in calves. Veterinary Clinics 
of North America: Food Animal Practice, 35(1): 37-54. 
 
Figure 1-10 Enlarged mesenteric lymph nodes often seen in calves with systemic salmonella 
infections. 
Adapted from Mohler VL, Izzo MM, House JK. (2009). Salmonella in calves. Veterinary Clinics 
of North America: Food Animal Practice, 35(1): 37-54. 
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Figure 1-11 Abomasal wall thickening and erosion of the mucosa and submucosa. 
Adapted from Mohler VL, Izzo MM, House JK. (2009). Salmonella in calves. Veterinary Clinics 
of North America: Food Animal Practice, 35(1): 37-54. 
 
Calves dying from chronic salmonellosis will show many of the lesions found in the 
acute disease syndrome; however, lesions of the large intestine will most often be more discrete 
and necrotic (Radostits, 1994). Signs of localization of infection in a variety of organs and 
tissues are frequently found (Rings, 1985). Some of these signs are fibrinopurulent synovitis of 
joints, fibrinopurulent bronchopneumonia and abscessation of the lungs, meningoencephalitis, 
osteomyelitis of the vertebrae and limbs, and ischemic necrosis of the skin of the ears and tail 
(O’Connor et al., 1972; Power and O’Keefe, 1991; Rings, 1985; Williams, 1980). 
Histopathological lesions in the liver comprise small foci of coagulative necrosis 
infiltrated by a few macrophages and mononuclear cells, referred to as typhoid nodules (Barker 
et al., 1993). Typhoid nodules are randomly scattered in all lobes of the liver, and can be 
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associated with thrombosis of central veins or blood vessels in portal triads (White et al., 1981). 
Mild to moderate infiltration of mononuclear cells into most portal triads is also present. 
Vasculitis that is sometimes accompanied by thrombosis of larger blood vessels in the triads, 
clumps of Gram-negative bacteria in sinusoids, and bile stasis may also be present (White et al., 
1981). Vascular lesions and necrotic foci similar to those found in the liver are normally present 
in the spleen, and may also be found in the lungs, lymph nodes, kidneys, and bone marrow 
(Barker et al., 1993).  
Lesions in the affected areas of the intestines show necrosis and ulceration of the mucosa, 
presence of moderate numbers of mononuclear cells and neutrophils in the lamina propria and 
submucosa, and vasculitis and thrombosis of some blood vessels in the submucosa (White et al., 
1981). Cellular debris, mucus, and fibrin adhere to the necrotic mucosa or this may be present in 
the lumen of the affected parts of the intestines. Salmonella bacteria may be observed 
microscopically as individual bacteria or colonies of organisms in areas of inflammation and 
necrosis (White et al., 1981).  
The lesions observed in adult cattle are similar to those observed in calves except that the 
enteritis is more hemorrhagic and fibrinous or necrotic (Barker et al., 1993; Kahrs et al., 1972; 
Stadler and Nesbit, 1990). Mammary infections may lead to chronic-active mastitis and 
supramammary lymphadenitis (Spier, et al., 1991). Cows that abort may show a purulent 
endometritis and necrotic hepatic foci (Hall and Jones, 1979). The chorioallantois is thickened, 
the chorionic surface is mottled red and grey, and cotyledons may be covered with a yellow 
exudate and contain remnants of maternal caruncle (Kennedy and Hibbs, 1993). Mineralization 
of areas of the placenta may be extensive and some villi contain large numbers of neutrophils 
(Kennedy and Hibbs, 1993). Many villi will be necrotic and capillaries in the chorionic arcade 
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will contain prominent bacterial colonies (Hall and Jones, 1979). The fetal liver may have 
multiple foci of suppuration and neutrophils may occasionally be seen in the bronchi with 
bacterial colonization of the bronchial epithelium (Kennedy and Hibbs, 1993). 
 Diagnostic assays 
The diagnosis of salmonellosis is based on the isolation of the causative organism, 
supported by the history, clinical signs, and lesions at necropsy (Anderson and Blanchard, 1989; 
Stadler and Nesbit, 1990). Specimens submitted to a diagnostic laboratory should be incubated in 
selective enrichment media, which enhances the chances of isolating the organisms. 
To diagnose salmonellosis in live animals, fecal specimens or rectal swabs should be 
submitted for bacterial isolation (Gitter et al., 1978; Palmer et al., 1985; Williams, 1980; Wray 
and Sojka, 1977). If the animal is suffering from severe diarrhea, the volume of feces may dilute 
the number of organisms to an extent preventing the successful isolation of the organisms from 
rectal swabs (Rings, 1985; Sojka et al., 1974). Salmonella bacteria may be isolated from the 
blood of septicemic animals (Segall and Lindberg, 1991; Stadler and Nesbit, 1990; White et al., 
1981; Williams, 1980; Wray and Sojka, 1977). Rectal mucosal biopsy is an easy and safe method 
to increase the chance of isolating Salmonella organisms, because of the adherent and invasive 
nature of the organism resulting in concentration on the mucosa (Palmer et al., 1985). 
Fresh liver, spleen, mesenteric lymph nodes, and affected intestinal specimens should be 
submitted for bacterial isolation (Smith et al., 1979). The above samples as well as specimens of 
the kidneys, brain, and lungs should be fixed in 10% buffered formalin and submitted for 
histopathological examination. The presence of typical necrotic foci and thrombosis are 
indicative of salmonellosis (Smith et al., 1979). 
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The diagnosis of carrier animals is more difficult because they shed bacteria 
intermittently, and it may take a number of fecal specimens before a positive culture is obtained 
(Wray and Sojka, 1977). Fecal culture and serology testing is usually negative for latent carriers 
(Wray et al., 1989). Since parturition may activate a latent infection, swabs of feces and vaginal 
discharge should be submitted for culture (Clegg et al., 1986; Richardson, 1973). Isolation 
should be attempted from the gall bladder, ileocecal lymph nodes, tonsils, female genital tract, 
supramammary lymph nodes and udder if a latent infection is suspected in a dead animal 
(Lawson et al., 1974; Richardson, 1973; Sojka et al., 1974; Spier et al., 1991; Wood et al., 
1991). 
Salmonella can be isolated from the organs and abomasal contents of aborted fetuses 
(Hinton, 1971). The placenta and vaginal mucus of cows that abort should also be submitted for 
bacterial isolation (Richardson, 1974; Williams, 1980).  
ELISA, serum agglutination, and complement fixation can be used for the retrospective 
diagnosis of salmonellosis or the detection of carriers (Carlson et al., 1973; Lawson et al., 1974 
(2), Spier et al., 1991; Wray and Sojka, 1977). However, these tests are only reliable when used 
on a herd basis (Radostits et al., 1994; Timoney et al., 1988). Antibody responses are much more 
consistent in animals that have suffered either bacteremia or septicemia (Hinton, 1974; Timoney 
et al., 1988).  Positive animals may not have positive serum titers because the serum was 
collected too early in the infection or the infection was not severe enough to stimulate a 
detectable humoral immune response (Gitter et al., 1978; Radostits et al., 1994; Timoney et al., 
1988). Latently infected cattle will remain serologically negative (Lawson et al., 1974). 
ELISAs have been developed primarily for the detection of S. Dublin or S. Typhimurium 
carriers, but due to cross-reacting O antigens, the assays have poor specificities (Hoorfar et al., 
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1996; Hoorfar and Wedderkopp, 1995; House et al., 1993; Konrad et al., 1994). More specific 
assays have been developed to identify S. Dublin carriers using fimbrial antigens or serogroup 
specific lipopolysaccharide (Hoorfar et al., 1996; Konrad et al., 1994). ELISAs have also been 
used to detect antibodies in both milk and blood (Hoorfar and Wedderkopp, 1995; House et al., 
1993; Konrad et al., 1994). 
Matrix assisted laser desorption ionization time of flight (MALDI-TOF) and real-time 
polymerase chain reaction (RT-PCR) have more recently been used in most veterinary diagnostic 
laboratories when a Salmonella infection is suspected. MALDI-TOF is a mass spectrometry 
assay that can actually detect Salmonella and type some of the most commonly isolated serovars 
from humans and animals (Dieckmann and Malorny, 2011). RT-PCR assays to diagnose 
Salmonella infections are more rapid, cost-effective, and reliable than standard bacteriological 
methods (Malorny and Hoorfar, 2005). These assays can detect Salmonella in very small 
numbers because they amplify the DNA of the bacteria. 
The clinical signs of salmonellosis in calves are very similar to those caused by many 
other infectious agents that affect the gastrointestinal tract. The most important include bovine 
coronavirus, rotavirus, and bovine viral diarrhea (BVD) virus I and II, Escherichia coli, 
Clostridium perfringens, Yersinia spp., Chlamydia spp., Eimeria spp., and Cryptosporidium spp 
(Radostits et al., 1994; Rings, 1985). Over-feeding, incorrect feeding, and feeding of milk-
replacers with denatured whey proteins may also cause clinical signs similar to salmonellosis 
(Radostits et al., 1994; Rings, 1985).  
The diarrhea associated with enteric salmonellosis in adult cattle can be bloody or 
dysenteric and should be differentiated from that caused by BVD virus, arsenic poisoning, 
helminths, and toxic plants (Radostits et al., 1994). Abortion caused by Salmonella infection 
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should be differentiated from that induced by other infectious agents such as BVD virus, Rift 
Valley Fever virus, Brucella abortus, and Leptospira. 
 Treatments 
Veterinarians disagree about the rationale and wisdom of treating cases of salmonellosis 
with antimicrobials because of their efficacy and likelihood of producing Salmonella carriers 
(Whitlock, 1984). The choice of drugs to be used ideally would be determined after antibacterial 
sensitivity of the isolate is determined. Some Salmonella isolates may be resistant to multiple 
antibiotics. However, early treatment based on a likely successful regimen must be used before 
the results are available. (Osborne et al., 1978) 
Treatment of salmonellosis in calves is directed at replacing fluid and electrolytes, 
limiting inflammatory cascades by treatment with non-steroidal inflammatory drugs (NSAIDs), 
and judicial use of antimicrobials. Parenteral fluid therapy can increase survival rates when 
administered intravenously (IV). Oral fluids can help animals survive periods of acute 
dehydration and toxemia. Intravenous hypertonic saline in combination with water or hypotonic 
sodium-contaminating fluid administered with a stomach tube is a useful treatment. Housing sick 
animals in a clean, dry, and climate-controlled environment can also improve outcomes. 
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Chapter 2 - Control and Prevention Strategies 
Salmonella infections of cattle can cause great economic losses. More importantly, 
infected animals can lead to contaminated milk, milk products, and processed beef. It is of vital 
importance for dairy and beef producers to prevent the introduction of Salmonella to their herds 
and to be able to control the spread of infection if an outbreak occurs. There have been several 
strategies to control and prevent the infection of calves and adult cattle, including the 
implementation of certain animal husbandry practices, cleaning and disinfection of animal 
housing, and vaccination. Each of these strategies should be used as part of a whole control and 
prevention program. 
 Animal Husbandry Practices 
Producers have control over a few risk factors for their herds based on management 
practices. The producer should purchase replacement stock from direct sources rather than 
dealers, quarantine purchased animals for a four-week period, house sick animals in dedicated 
isolation areas, prevent wild bird access to cattle and feed storage areas as much as possible, and 
vaccinate their animals. The aforementioned measures are likely to have a great impact on the 
reduction of salmonellosis (Aarestrup et al., 1997; Evans and Davies, 1996).  
Treatment and isolation or elimination of animals affected by salmonellosis, as well as 
disinfection of animal housing areas should be implemented to prevent the buildup of 
environmental contamination of bacteria (Spier et al., 1991). Efforts should be made to detect 
carrier animals and those animals should be culled from the herd (Spier et al., 1991).  
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 Cleaning and Disinfection of Animal Housing 
The institution and maintenance of hygiene and good animal husbandry practices is of 
paramount importance to controlling and preventing Salmonella infection. Feces should be 
removed from housing pens to slurry pits on a regular schedule. Survival of Salmonella in slurry 
is dependent on temperature, oxygen, and pH. Storing slurry in high temperatures, aerobic 
conditions, and at low pH will decrease the survival of Salmonella. According to the New York 
State Cattle Health Assurance Program (NYSCHAP), spreading slurry on flat land to dry and to 
be exposed to UV radiation from the sun will also decrease the amount of Salmonella that can 
survive. Feed storage areas should be kept rodent free, separate milk pails that are washed and 
disinfected after each use should be used for each calf, suitable housing should be provided to 
prevent overcrowding (Gitter et al., 1978). All-in all-out policies with thorough cleaning and 
disinfection between batches of calves have been effective (Hinton et al., 1983). 
Many disinfectants are effective against Salmonella, but external environments and 
fomites should be steam cleaned then disinfected with phenolic-, chlorine- or iodine- based 
disinfectants (Hess et al., 1970; Kennedy and Hibbs, 1993; Sojka et al., 1974). Five percent 
formalin can be sprayed several times on earthen floors (Meara, 1973). Carcasses of infected 
animals should be incinerated. Slurry should be used on crops (that are not root crops), but not 
on pastures intended for grazing (Radostits et al., 1994). 
 Vaccination 
Salmonella infections of calves usually reflect a variety of animal management and 
environmental factors that result in compromised host immunity and increased pathogen 
exposure. “Although the implementation of sound nutritional and environmental programs that 
maintain and/or promote broad-based host immunity contributes to livestock health 
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and productivity, reliable implementation of these management programs is a formidable 
challenge with numerous variables to consider, such as weather, mechanical failures, 
variable feedstuff availability and quality, and labor compliance issues” (Mohler et al., 2008).  
Vaccination is one of the best forms of prophylaxis against infection by Salmonella, but it 
is often insufficient to be effective on its own (Clegg et al., 1986). The effectiveness of 
Salmonella vaccines are influenced by the variety of Salmonella serovars that each animal is 
exposed to as well as the length of time between vaccination and exposure (Mohler et al., 2011). 
Animals that are exposed to Salmonella shortly after vaccination may not have developed an 
immune response, and the animal may not be protected. Most commercial vaccines do not 
protect against heterologous challenges, so if an animal has not been vaccinated against the 
serovar of Salmonella it is exposed to, the animal may become infected. It is this type of 
situation that necessitates the need for the development of broadly cross-protective bovine 
Salmonella vaccines. 
The other control and prevention strategies previously discussed also need to be 
implemented. Immunity to infection by Salmonella is thought to require both humoral and 
cellular immune responses. Humoral immune responses are those that involve antibodies against 
the pathogen while cellular immune responses are those responses that are cell-mediated, such as 
phagocyte activation, antigen-specific cytotoxic T-lymphocytes, and the release of various 
cytokines. 
Vaccines are generally grouped into three categories: killed or inactivated, live 
attenuated, and subunit. Live attenuated vaccines are considered to provide more complete and 
longer lasting immunity to pathogens because they mimic a natural infection without causing 
clinical disease and confer both humoral and cellular immunity. Killed or inactivated vaccines 
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generally only confer humoral immunity, and therefore, considered less effective than live 
attenuated vaccines. 
 There are very few commercially available bovine Salmonella vaccines available in the 
United States (Table 2-1).  Antimicrobial drugs should not be administered within the 
withdrawal period for the drug prior to or two weeks after the administration of a live attenuated 
Salmonella vaccine because the vaccine strain bacteria will need to be able to colonize the gut 
mucosa to be effective.   
Table 2-1 Current commercially available bovine Salmonella vaccines in the U.S. 
United States Department of Agriculture Current Veterinary Biologics Catalog. July 5, 2017. 
https://www.aphis.usda.gov/animal_health/vet_biologics/publications/CurrentProdCodeBook.pdf 
Accessed on 23July2017. 
Name of Vaccine Company Type of Vaccine 
Salmonella Serovars 
Protected Against 
SRP® Salmonella
1 
Zoetis Subunit Newport 
Super Poly-Bac® Texas Vet Lab, Inc. Killed Typhimurium 
Salmonella Dublin-
Typhimurium bacterin 
Colorado Serum 
Company 
Killed Dublin, Typhimurium 
SDT Guard™ 
Boehringer Ingelheim 
Vetmedica 
Killed Dublin, Typhimurium 
Entervene®-D 
Boehringer Ingelheim 
Vetmedica 
Live Attenuated Dublin 
Salmo Guard® Agri Labs Killed Dublin, Typhimurium 
Endovac® IMMVAC, Inc. Killed Typhimurium
2 
1) Vaccine granted only a conditional license. Efficacy tests are in progress. 
2) Claims broad cross-protection against Gram-negative bacteria. Only licensed for 
protection against S. Typhimurium. 
 
 Killed Salmonella vaccines 
Almost all of the commercially available bovine Salmonella vaccines in the U.S., 5 of 7 
vaccines, are killed vaccines (Table 2-1). Killed Salmonella bacterins are normally administered 
twice with two to four weeks between doses. Bacterins are usually ineffective in calves under six 
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weeks of age. Bacterins are sometimes administered to pregnant cows to provide calves with 
colostral immunity, which can last for approximately six weeks (Radostits et al., 1994).  
Of the 5 commercially available killed vaccines in the U.S., 4 claim protection against 
just 1 or 2 serovars. Endovac®, licensed by IMMVAC, Inc., claims broad cross-protection 
against 99% of Gram-negative bacteria. Endovac® is a Salmonella Typhimurium bacterin-toxoid 
that uses an antigen without the outer O-side chains. This exposes the cell wall of the naked core 
bacterin. Since the cell wall antigens of Gram-negative bacteria are conserved, IMMVAC, Inc. is 
confident in claiming the broad cross-protection. Endovac® has been tested for its efficacy to 
prevent clinical coliform mastitis, which has been proven. The vaccine may also protect against 
endotoxemia in calves caused by multiple Salmonella serovars, but it has not been proven to be 
efficacious against enteric salmonellosis (McClure et al., 1994). 
An inactivated commercial Salmonella Typhimurium vaccine is effective against S. 
Typhimurium challenge (Steinbach and Meier, 1990), but the vaccine does not confer protection 
against heterologous challenges. This vaccine was combined with other killed antigens to create 
another vaccine that is commercially available in the U.S. 
Immunization of dams 7 and 2 weeks prior to parturition with formalin-killed S. 
Typhimurium is safe and effective for preventing illness in calves (Jones et al., 1988) when 
challenged with a homologous S. Typhimurium. This type of vaccination strategy gives a short-
lived passive immunity transferred to the calf via colostrum (Cortese, 2009). 
 Live Attenuated Salmonella vaccines 
Live, attenuated Salmonella vaccines have been assessed in cattle. These vaccines are 
considered to induce better protection than killed vaccines due to their ability to stimulate both 
cellular and humoral immune responses (Villarreal et al., 1998). The most widely tested strains 
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are auxotrophic strains. These strains can only grow when they are provided with a specific 
substance. Live, attenuated vaccines are generated mainly through targeted gene deletion of 
genes shown to be necessary for the pathogen in the host. Aromatic amino acid (aro) and purine 
(pur) auxotrophs are attenuated and stimulate protective immunity (Stocker, 1988). Purine and 
histidine auxotrophs of S. Typhimurium and S. Dublin have been administered orally in cattle in 
Germany for over 20 years with no reversion to virulence detected (Meyer et al., 1992; Rabsch et 
al., 2001), but they confer protection only against homologous challenges.  
Live vaccines should carry defined and multiple attenuating mutations and genetic 
markers to distinguish them from wild-type strains and to prevent the bacteria from reverting to a 
form that can cause disease. For example, a double mutated S. Typhimurium strain at gene 
locations aroA and aroD has been shown to protect calves from virulent S. Typhimurium (Jones 
et al., 1991; Villarreal et al., 1998).  
The only commercially available modified live bovine Salmonella vaccine in the U.S. is 
Entervene®-D, licensed by Boehringer Ingelheim Vetmedica. The vaccine strain in Entervene®-
D is a S. Dublin with a gene deletion in the aroA gene. Entervene®-D is administered as a 2 mL 
subcutaneous dose with a booster dose administered two weeks later. The efficacy of this 
vaccine was examined in 2011 by Habing et al. The research group concluded that administered 
as the label described, the vaccine reduces clinical disease in calves challenged with only a 
homologous S. Dublin, but the vaccine does not confer protection when administered off label as 
an oral vaccination. 
A modified live S. Choleraesuis vaccine administered by intramuscular injection reduces 
the fecal shedding of serogroup C1 organisms by both cows and calves (House et al., 2001). The 
vaccine confers protection against heterologous challenges, but not challenges that don’t belong 
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to the same serogroup as S. Choleraesuis. The limited cross-protection of this vaccine could lead 
to a more broadly cross-protective vaccine. This vaccine has been licensed for use in swine, but 
not for use in cattle. 
 Subunit Salmonella vaccines 
Subunit vaccines are composed of fractions of pathogens that are purified or are 
generated using recombinant DNA technology. Subunit vaccines are designed to isolate antigens 
that elicit immune responses without adverse reactions or immunosuppression (Liljeqvist and 
Ståhl, 1999). Only 1 subunit Salmonella vaccine is commercially available for use in cattle in the 
U.S. Zoetis has licensed SRP® Salmonella, which is composed of highly purified extracts of S. 
Newport proteins known as siderophore receptors and porins (SRP). In short, SRP allow for the 
transfer of iron into the cell, a critical requirement for bacterial survival. In one field trial, SRP 
Salmonella had no effect on fecal prevalence of Salmonella or health and performance of the 
animals (Dodd et al., 2011a) 
The few commercially available bovine Salmonella vaccines available in the U.S. lack 
the ability to confer cross-protection against heterologous challenges to vaccinated animals. Most 
of the vaccines are killed bacterins, which have a limited efficacy even against homologous 
challenges. None of the killed bacterins confer cross-protection. One live attenuated vaccine is 
currently available in the U.S., but the vaccine only protects against homologous challenge and 
needs to be administered more than once. Only one subunit Salmonella bovine vaccine is 
available in the U.S. The lone subunit vaccine did not show any effect in one field trial. The 
subunit vaccine is also only conditionally licensed. Since all of the available vaccines have 
significant limitations, researchers should focus on the development of a broadly cross-protective 
Salmonella bovine vaccine. 
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Chapter 3 - Future Challenges and Research Opportunities 
Although Salmonella vaccines are commercially available for cattle (as discussed in 
Chapter 2), more research needs to be performed due to several reasons. The limited options of 
commercially available bovine Salmonella vaccines, there are only 7, means that producers are 
all giving the same vaccines. The current vaccines all have severe limitations. None of the 
vaccines are cross-protective against challenge with serovars belonging to different serogroups. 
The one available subunit vaccine, SRP® Salmonella, was found not to be effective in one field 
trial. Researchers need to focus on developing more effective and broadly cross-protective 
Salmonella vaccines.  
 Limitations of currently available vaccines 
Salmonella Typhimurium and S. Enteritidis are heavily researched. Most licensed 
veterinary Salmonella vaccines are targeted to elicit protection against these two serovars. Since 
so much research effort is dedicated to S. Typhimurium and S. Enteritidis, they belong to 
serogroups B and D respectively, serogroup C serovars are not targeted to the extent that they 
should be. Of the 10 serovars most commonly isolated from humans in the United States, 5 
belong to serogroup C (See table 3-1). Of the serovars most commonly isolated from cattle 3 
belong to serogroup C. S. Dublin (serogroup D), S. Cerro (serogroup K), S. Anatum (serogroup 
E) are also serovars of interest when discussing Salmonella in cattle. All three of these serovars 
have been isolated from human clinical Salmonella infections. S. Anatum is rarely implicated in 
human disease, but is the most commonly isolated serovar from cattle (Table 1-1). 
Of the 10 most commonly isolated Salmonella serovars in humans, 7 of the serovars are 
also isolated in cattle (CDC, 2013). This fact highlights the zoonotic potential of Salmonella. As 
discussed in Chapter 1, ground beef and milk and dairy products have been implicated in many 
42 
outbreaks of human salmonellosis. To reduce this risk, a broadly cross-protective vaccine 
capable of preventing enteric disease and reducing fecal shedding of Salmonella bacteria in cattle 
needs to be developed. The current vaccines lack the capability to protect cattle against 
Salmonella serovars that belong to the same serogroup, and they also do not protect against 
challenge with serovars from different serogroups than the vaccine strain. 
 
Table 3-1 Most commonly isolated Salmonella serovars from humans in the United States. 
Information obtained from the Centers for Disease Control National Enteric Disease 
Surveillance: Salmonella Annual Report, 2013 
https://www.cdc.gov/nationalsurveillance/pdfs/salmonella-annual-report-2013-508c.pdf 
 
Rank Serotype Serogroup 
1 Enteritidis D 
2 Typhimurium B 
3 Newport C2 
4 Javiana D 
5 Heidelberg B 
6 Infantis C1 
7 Saintpaul B 
8 Muenchen C2 
9 Montevideo C1 
10 Braenderup C1 
 
Salmonella can infect many organs in cattle, and there is a potential for it to contaminate 
beef products. Processed beef may become contaminated by contact with hide that has 
Salmonella on the surface or by the addition of infected PLNs in ground beef (Olafson et al., 
2016). Vaccines for cattle have been developed to either prevent enteric disease in cattle or to 
reduce carriage in the PLNs, reducing the likelihood of bacterial contamination of beef products.  
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Interestingly, the peripheral lymph nodes can become infected without an animal 
suffering from enteric disease. The mechanism of infection in these cases is most likely 
associated with biting arthropods, especially horn flies (Olafson et al., 2016).  
 Need for cross-protective vaccines 
Human foodborne Salmonella outbreaks are occurring with unprecedented regularity 
(CDC, 2012). Salmonella control efforts are difficult due to the bacterium’s high tolerance to 
environmental stress, adaptability, multidrug resistance and widespread distribution in animal 
and environmental reservoirs (Mahan et al., 2012). Control efforts are expensive with recent 
estimates of $14.6 billion annually in the U.S. (Gilliss et al., 2011; USDA, 2011; Scharff, 2010). 
The intensification of livestock production and the emergence of strains with greater capacities 
to cause human and animal diseases will likely increase the health and economic costs related to 
Salmonella infections. According to the Foodborne Diseases Active Surveillance Network 
(FoodNet), Salmonella causes more foodborne disease than any other food-borne pathogen in the 
U. S. (Gilliss et al., 2011; Scallan et al., 2011). Many Salmonella serovars infect both humans 
and animals.  
The diversity of Salmonella found on farms and feedlots, as well as the potential for 
strains that are more capable of producing disease in animals and humans, necessitates the use of 
prophylactic strategies that are effective against several serovars. For many years, antibiotics 
have been given therapeutically and prophylactically, but this strategy is becoming limited under 
the Veterinary Feed Directive (VFD). The VFD was written due to the emergence of multidrug-
resistant bacteria, including Salmonella, which present a risk to human health (Brichta-Harhay et 
al., 2011; Hur et al., 2012). Vaccination is one of the best forms of prophylaxis against infection 
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by Salmonella, but commercially available vaccines confer protection limited to a specific strain 
or closely related set of strains.  
 Salmonella of several different serotypes from several serogroups are capable of infecting 
cattle. For example, S. Heidelberg and S. Typhimurium are both serogroup B organisms, S. 
Newport is found in serogroup C, S. Dublin is in serogroup D, and S. Cerro is in serogroup K, all 
of which infect cattle. All of these serovars are also capable of infecting humans as well. 
According to the CDC National Enteric Disease Surveillance: Salmonella Annual Report, 2013, 
all of the aforementioned serovars have caused multi-state outbreaks in humans through 
consumption of contaminated ground beef, milk or other dairy products. 
Development of a bovine vaccine that displays broad cross protection against Salmonella 
in multiple serogroups is a difficult proposition, but it is a challenge that many research groups 
are trying to solve. The variety of virulence factors with varying epitopes between serogroups, 
and even between serovars of the same serogroup, is a challenge that no researcher has been able 
to overcome yet. However, there are some vaccines that have the possibility of cross-protection. 
Convincing producers to vaccinate their herds for each Salmonella serogroup 
individually, is a near impossibility. Even if vaccines were developed that would protect animals 
against an entire serogroup, adherence to a vaccination schedule with 3-5 Salmonella vaccines is 
not practical. The best way to convince dairy and beef producers to vaccinate their animals 
against Salmonella is to develop a single vaccine that is, not only economical, but broadly cross-
protective against multiple serogroups.  
 Vaccine challenge model development 
 Since recent research has determined that Salmonella bacteria commonly harbors in 
PLNs of cattle presented for harvest (Arthur et al., 2008; Haneklaus et al., 2012; Koohmaraie et 
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al., 2012). A challenge model that is predictable and reproducibly causes infection of PLNs by 
Salmonella would be ideal in order to prove efficacy of vaccines. The main goal of many 
vaccines is to reduce the carriage of Salmonella by the PLNs, since PLNs are frequently included 
in ground beef. If infected lymph nodes are included in ground beef, there is a possibility of an 
outbreak in humans, especially if the beef is not completely cooked. Edrington et al. (2013) 
developed a transdermal challenge model for the infection of PLNs by Salmonella. In short, the 
research group used a 10-lancet allergy testing instrument to transdermally inoculate calves with 
either Salmonella Newport or Salmonella Montevideo in one of the hind legs. Each calf was also 
inoculated by the transdermal route with Salmonella Senftenberg in the lower abdomen. The 
PLNs were predictably infected after inoculation by the transdermal route and the serogroups 
recovered from the PLNs that drain the challenge region matched in all but one instance, 
suggesting a reproducible regionally specific Salmonella infection of PLNs. 
 Oral Salmonella challenge models of calves have been around for many years. The 
development of oral Salmonella challenge models is centered on the induction of enteric disease 
symptoms that would occur in natural infections by ingestion of fecal material. The challenge 
dose is determined for each Salmonella isolate by testing multiple doses and comparing the 
severity of disease based on a clinical scoring system. The clinical scoring system will normally 
include, but is not limited to, the following: appetence, fecal appearance, dehydration, animal 
activity (lethargy), and rectal temperature. A successful challenge model allows for the 
development of disease over several days, without killing animals due to endotoxic shock. 
Dependent on the challenge isolate, Salmonella organisms may be isolated from feces, small 
intestine, lung, liver, spleen, mesenteric lymph nodes, gall bladder, joint fluid, and PLNs. 
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 Targets for candidate vaccines 
Many researchers are focusing their efforts on developing Salmonella subunit vaccines 
for cattle. Recent research, primarily associated with many of the Salmonella virulence factors 
discussed in Chapter 1, has revealed new antigen targets for vaccine development. Some of the 
targets described below are conserved among Salmonella, so they will potentially be able to 
elicit an immune response that will protect against many serovars. 
 Proteins of the type III secretion system 
The type III secretion system is a virulence factor for all Salmonella, as discussed in 
Chapter 1. The type III secretion system is a needle-like structure that deliver virulence proteins 
to target host cells. Type III secretion system-1 mediates Salmonella invasion of epithelial cells, 
and type III secretion system-2 is essential for macrophage survival (Forest et al., 2010; 
Raffatellu et al., 2008). The virulence proteins delivered to the host macrophage through the type 
III secretion system-2 allow for the bacteria to control SCV membrane dynamics, position SCVs 
within host cells, control immune modulation and cytoskeletal modifications, and affect the 
motility of infected cells. 
 The proteins at the tip of the type III secretion system are conserved among Salmonella 
serogroups and serovars, making these proteins good candidates for a cross protective subunit 
vaccine. Several research groups are working on subunit vaccines focusing on the proteins of the 
type III secretion system. Based on previous work on the type III secretion system tip protein of 
Shigella flexneri, IpaD, the tip protein of the Salmonella Typhimurium type III secretion system, 
SipD, has been targeted as a potential vaccine candidate (Markham et al., 2010). Mice injected 
with SipD displayed high antibody titers and had increased titers upon booster vaccination. More 
than one booster vaccination did not show a marked increase in antibody titer. SipD antibody 
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responses were lower in magnitude than for IpaD, suggesting that this protein may be less 
immunogenic (Markham et al., 2010). Mice were also injected with a complex of the needle 
proteins, Prgl and SipD. This complex resulted in a lower IgG response than when injected with 
SipD alone. This result would indicate that a subunit vaccine containing only SipD would be 
more efficacious than a vaccine containing both Prgl and SipD. 
The Markham research group should challenge mice with a heterologous challenge, 
preferably a serogroup C serovar for reasons explained in Chapter 2. If the vaccine can protect 
against a heterologous challenge, the research group should conduct a study to evaluate the 
efficacy of the vaccine in cattle. Based on previous work with a related bacterium, Shigella 
flexneri, the SipD vaccine has the potential to protect calves against enteric disease caused by 
Salmonella infection. 
 Outer membrane proteins 
Outer membrane proteins that are conserved between many serovars of Salmonella may 
be good targets for subunit vaccines. Outer membrane proteins are exposed to the antigen 
presenting cells of the immune system. This leads to a greater chance of recognition of a 
pathogen, because the outer membrane proteins are more accessible. Two of the proteins 
identified as being suitable vaccine candidates are outer membrane protein A (ompA) and phoP-
activated gene C (pagC).  
Outer membrane protein A has been shown to activate dendritic cells. Lee et al. (2012) 
proved that exposure to a purified ompA from S. Typhimurium caused “phenotypic and 
functional maturation of dendritic cells”. This research shows that a vaccine made from ompA 
could be effective in stimulating an adaptive immune response.  
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PhoP, described in Chapter 1 as a portion of a two component regulatory system, is the 
transcriptional regulator for pagC. When pagC is singly mutated, the virulence of S. 
Typhimurium in mice is affected. PhoP also regulates the transcription of other proteins. 
Multiple mutations in the PhoP regulated proteins could result in highly attenuated, but still 
efficacious, live vaccine strains (Miller et al., 1993). Since PhoP and pagC are highly conserved 
among many Salmonella serovars, these could be potential antigen targets for a cross-protective 
vaccine candidate. 
A suicide vector has been developed to delete the pagC gene and replace it with other 
antigen genes within the pagC locus (Miller et al., 1993). If pagC is not antigenic enough to elicit 
a strong immune response, a more immunogenic antigen could be inserted into the pagC locus 
and will be transcribed when PhoP would normally be regulating the transcription of pagC. This 
could possibly result in a live attenuated strain of Salmonella, which produces an antigen that can 
confer cross-protection against several Salmonella serovars. 
 Fimbrial proteins 
As described in Chapter 1, fimbriae are virulence factors of Salmonella. One specific 
fimbrial protein, CsgF, has been identified as a possible vaccine candidate. CsgF is a protein 
found in a specific type of fimbriae, curli. Curli are a type of proteinaceous cell surface filament 
produced by enteric bacteria, such as Escherichia and Salmonella, that facilitate cell adhesion 
and invasion, bio-film formation, and environmental persistence (Green et al., 2016). The 
function of curli is as a chaperone molecule to help CsgA assemble into curli (Green et al., 
2016). If a subunit vaccine is developed against curli, the adhesion to and the invasion of the gut 
mucosa by all Salmonella serovars could potentially be avoided.  
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 Flagellar proteins 
The major component of Salmonella flagella is fliC. Flagella are also virulence factors of 
Salmonella that allow the bacteria to be motile. A recombinant fliC protein vaccine has been 
tested for efficacy in chickens. The vaccine showed limited efficacy and further improvement is 
needed, but the bacterial counts in organs normally affected by Salmonella infection was 
significantly reduced when challenged with a homologous organism (Okamura et al., 2012). To 
create a subunit vaccine capable of cross-protection from flagellar proteins, fliC from several 
serotypes associated with cattle would need to be included in the vaccine. 
 
 Future Research 
Future research will need to focus on correlation between antibody response and its 
ability to provide protective immunity in mice and then in cattle. This protection needs to be 
evaluated for both transdermal and oral challenge models. As vaccines are developed that can 
protect mice and/or cattle against a homologous challenge, they should be evaluated for cross-
protection against serovars in the same serogroup as well as serovars in other serogroups. 
An extensive literature review showed no research of proteomic arrays Salmonella-
specific immune targets for the serotypes that most commonly infect cattle. A proteomic array 
was developed and 8 new immune targets identified for Salmonella Typhi (Lee et al., 2012). A 
similar research project could be conducted for several Salmonella serotypes to identify more 
antigenic components of the bacteria. To do this, the genome of isolates of Salmonella to be used 
would need to be sequenced and open reading frames chosen based on if they code for single 
proteins or their homology to other Salmonella serovar isolates. As the Lee (2012) research 
group performed, the proteins would then be expressed and printed onto nitrocellulose 
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membranes. The arrays could then be probed with serum from infected and noninfected mice and 
cattle to determine which proteins gave only significant responses to sera from infected mice or 
calves. Any proteins that are found to give significant responses to sera from infected animals 
and to multiple serovars could then be evaluated further for the potential to be used in cross-
protective vaccines. 
As discussed earlier in this report, live attenuated vaccines are widely considered to 
confer the best and longest lasting immune response. Developing a live attenuated vaccine that 
can confer cross-protection should be of high importance. While many groups are researching 
live attenuated vaccines, none have been found that are broadly cross-protective.  
Mutations in the dam gene of Salmonella, preventing expression of the DNA adenine 
methylase, also result in highly attenuated organisms (Heithoff et al., 2015). Vaccination of 
calves with an attenuated S. Typhimurium dam strain conferred protection against calves via 
both adaptive immunity and competitive exclusion mechanisms (Dueger et al., 2003). 
Immunization of young calves with a similar strain resulted in reduced clinical disease, reduction 
of fecal shedding, and reduction of lymph node colonization by heterologous S. Dublin and S. 
Newport challenge compared to non-vaccinated animals (Mohler et al., 2006, 2008). This 
vaccine strain needs to be evaluated for efficacy against more heterologous challenges, 
especially challenges of Salmonella serovars contained in Table 1-2. This vaccine is not licensed 
and is not commercially available. 
Cross-protective Salmonella vaccine development is an area of interest of several 
research groups as described above. Each research groups has a different approach to vaccine 
development. Some research groups are developing subunit vaccines. One limitation of subunit 
vaccines is that many times the amount of antigen needed to confer protection makes the 
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production of the vaccine cost prohibitive. Sometimes addition of adjuvants, materials designed 
to stimulate a stronger immune response, can alleviate this issue, but many times it cannot.  
At least one research group has developed a live attenuated vaccine strain of Salmonella 
Typhimurium that can protect against heterologous challenges of one serovar in each of 
serogroup C and D. Live attenuated vaccines have an inherent advantage over subunit vaccines 
in that the live vaccine strains will replicate within the host for a time, producing more antigen 
load than what was in the original vaccine. Live attenuated vaccines also rely on more than one 
antigen of the vaccine strain. These two factors increase the possibility that a live attenuated 
vaccine will be not only efficacious, but it will also be economical. 
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Chapter 4 - Discussion and Conclusions 
Salmonella occurs worldwide and is a leading cause of acute bacterial gastroenteritis in 
people. Salmonella infection is the leading cause of foodborne illness in the U.S. Ground beef is 
one of the major causes of human Salmonella infections in the U.S., with milk and other dairy 
products also contributing to the number of human Salmonella infections. While there are many 
control and prevention options, a comprehensive program should be developed. Vaccination 
should be part of any Salmonella control and prevention program because it is one of the most 
effective forms of prophylaxis against the development of salmonellosis.  
Several serotypes of Salmonella can infect cattle and can also be shed by cattle. These 
serotypes belong to several serogroups. Since serovars are defined by their poly-O (cell wall) and 
H (flagellar) antigens, and these antigens are also considered virulence factors, vaccines 
developed for one serovar may not be protective for other serovars or serogroups. A cross-
protective Salmonella vaccine would solve a problem of vaccinating animals for several 
Salmonella serotypes.  
 Most beef and dairy producers will not adhere to a vaccination schedule that requires 
multiple vaccinations for Salmonella. According to the USDA NAHMS Dairy 2014 Report, only 
2.5% of dairy operations vaccinated cattle against Salmonella. The USDA NAHMS Beef 2007-
08 Report shows only 0.5% of cow-calf operations vaccinated against Salmonella, while the 
USDA NAHMS Beef 2011 Report shows that only 5.2% of feedlot cattle are vaccinated against 
Salmonella. These facts makes the development of a cross-protective vaccine a priority. Many 
research groups are working towards the development of just such a vaccine. There are many 
strategies among the research groups, and the strategy depends on what part of the disease the 
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vaccine targets. Some vaccines will target peripheral lymph node colonization, since the 
peripheral lymph nodes have been implicated in contamination of ground beef. Other vaccines 
will try to prevent the gut mucosa from being colonized so that fecal shedding is reduced and 
carrier animals are not produced from subclinical infections.  
Most vaccines that are being researched to prevent the colonization of the peripheral 
lymph nodes are subunit vaccines. The most successful subunit vaccines so far are made of 
proteins of the type III secretion system, one of the many virulence factors of Salmonella. The 
potential for these subunit vaccines to be cross-protective comes from the fact that the type III 
secretion system needle tip proteins are highly conserved among Salmonella serovars.  
Live attenuated vaccines are being developed to prevent the colonization of the gut 
mucosa and to reduce the amount of shedding of Salmonella in the feces. Live attenuated 
vaccines are preferable to subunit vaccines because they generally confer humoral and cellular 
immunity. Live attenuated vaccines also have the potential to present many antigens to the host, 
any one of which could be cross-protective to another serovar. Several research groups seem to 
be close to developing a live attenuated vaccine that confers protection against several 
Salmonella serovars, but so far none are broadly cross-protective. 
With continued research, a vaccine that is cross-protective against several serovars and 
serogroups is obtainable. For now, research should focus on vaccines that protect cattle against 
serotypes in serogroups E, C1, and C3 since serotypes in these serogroups account for most of the 
isolations of Salmonella from cattle. Of the 10 Salmonella serovars most commonly isolated 
from humans (Table 3-1), seven of them are also isolated from cattle. Another serogroup, D, 
should be targeted for vaccine development because serovars from that group, such as S. Dublin, 
tend to cause a more severe clinical disease in calves.  
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The development of cross-protective Salmonella vaccines will give producers another 
option to combat a disease for which a large amount of money is spent to control and prevent. 
These cross-protective vaccines could also increase the productivity of the cattle and protect our 
food supply.  
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